tim ramey is an analyst with pivotal research group. one of herbalife's biggest shareholders. tim, welcome to the show. >> thank you so much. >> why do you think a settlement is coming? >> well, there are really two issues here. one is the bostic class action where both sides have been in productive negotiations and recently petitioned the court for a two-week extension that ends on november 10th. so sometime between now and november 10th there's a reasonable likelihood we get the bostic class action put to bed, and i think that will be important for the stock. could happen on monday but no reason that monday is particularly sacred from that standpoint. >> so i'm curious, tim, in terms of your price target, which is practically double where the stock is right now, you know, what other catalysts do you see out there aside from settlements of investigations or lawsuits? i mean, aside from potentially settling with the class action lawsuit there could be the ftc investigation goes away. that could be another catalyst. what are some of the